OptimizeRx Corporation (OPRX)Healthcare | Health Information Services | Waltham, United States | NasdaqCM
7.95 USD
+0.12
(1.533%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.95 |
Hot Take ↕ | Aug. 22, 2026, 2:16 a.m. EDT
The investment case for OptimizeRx is currently fractured by a severe divergence between analyst optimism and operational reality. While the forward P/E suggests a cheap entry relative to future earnings expectations, the company is actively cutting revenue by nearly 30%, a trend confirmed by recent headlines detailing a miss in both revenue and EPS. This contraction in top-line growth is the primary driver for the neutral long-term rating; without a clear pivot to profitability or a recovery in sales, the current valuation lacks a sustainable foundation. In the short term, the stock is showing signs of a technical rebound, having recovered some ground from its lows, yet the momentum remains fragile. The recent price action is volatile, and the statistical forecasting models offer virtually no directional guidance due to extreme noise in the data. Crucially, the options market tells a starkly different story than the recent price chart: traders are overwhelmingly buying puts, betting on further declines rather than participating in the rally. This disconnect suggests the recent price gains may be a temporary relief rally rather than a trend reversal. Finally, there is no dividend component to consider here. The company has not issued dividends in the last five years, reflecting its focus on capital retention during this period of restructuring and revenue contraction. Investors seeking income will find nothing here. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.167414 |
| MSTL | 0.180084 |
| AutoETS | 0.180306 |
| AutoARIMA | 0.180311 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 24.96 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.122 |
| Excess Kurtosis | -1.14 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.861 |
| Revenue per Share | 5.277 |
| Market Cap | 149,745,808 |
| Trailing P/E | 31.80 |
| Forward P/E | 7.52 |
| Beta | 1.05 |
| Profit Margins | 4.66% |
| Website | https://www.optimizerx.com |
As of Aug. 22, 2026, 2:16 a.m. EDT: Speculators are heavily positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (100% of total put volume) compared to negligible call activity. The strike distribution shows significant hedging at the $5.00 level, while call volume is sparse and concentrated at lower strikes, indicating a lack of aggressive bullish sentiment despite the recent price bounce.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5437063 |
| Address1 | 260 Charles Street |
| Address2 | Suite 302 |
| All Time High | 99.18 |
| All Time Low | 0.6 |
| Ask | 10.13 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 200,540 |
| Average Daily Volume3 Month | 329,091 |
| Average Volume | 329,091 |
| Average Volume10Days | 200,540 |
| Beta | 1.048 |
| Bid | 7.9 |
| Bid Size | 1 |
| Board Risk | 1 |
| Book Value | 6.96 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.95 |
| Current Ratio | 5.576 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 8.09 |
| Day Low | 7.62 |
| Debt To Equity | 14.861 |
| Display Name | OptimizeRx |
| Dividend Date | 1,526,256,000 |
| Earnings Call Timestamp End | 1,786,566,600 |
| Earnings Call Timestamp Start | 1,786,566,600 |
| Earnings Timestamp | 1,786,564,800 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 15,551,000 |
| Ebitda Margins | 0.15763 |
| Enterprise To Ebitda | 9.333 |
| Enterprise To Revenue | 1.471 |
| Enterprise Value | 145,129,808 |
| Eps Current Year | 0.89 |
| Eps Forward | 1.0575 |
| Eps Trailing Twelve Months | 0.25 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.589 |
| Fifty Day Average Change | 1.3609996 |
| Fifty Day Average Change Percent | 0.2065563 |
| Fifty Two Week Change Percent | -54.37063 |
| Fifty Two Week High | 22.25 |
| Fifty Two Week High Change | -14.3 |
| Fifty Two Week High Change Percent | -0.6426966 |
| Fifty Two Week Low | 4.54 |
| Fifty Two Week Low Change | 3.4099998 |
| Fifty Two Week Low Change Percent | 0.7511013 |
| Fifty Two Week Range | 4.54 - 22.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,196,260,200,000 |
| Float Shares | 14,480,137 |
| Forward Eps | 1.0575 |
| Forward P E | 7.51773 |
| Free Cashflow | 15,760,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 132 |
| Fullday Change | 0.12 |
| Fullday Change Percent | 1.53257 |
| Fullday Price | 7.95 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.73222 |
| Gross Profits | 72,236,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.1383 |
| Held Percent Institutions | 0.69688004 |
| Implied Shares Outstanding | 18,835,951 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,526,256,000 |
| Last Split Factor | 1:3 |
| Long Business Summary | OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts. |
| Long Name | OptimizeRx Corporation |
| Market | us_market |
| Market Cap | 149,745,808 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_52289160 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 4,601,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 148,615,653 |
| Number Of Analyst Opinions | 5 |
| Open | 7.83 |
| Operating Cashflow | 18,434,000 |
| Operating Margins | -0.00429 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.61 |
| Phone | 248 651 6568 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 7.95 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 7.83 |
| Price Eps Current Year | 8.932584 |
| Price Hint | 2 |
| Price To Book | 1.1422414 |
| Price To Sales Trailing12 Months | 1.5178889 |
| Profit Margins | 0.04664 |
| Quick Ratio | 5.274 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.16667 |
| Region | US |
| Regular Market Change | 0.12 |
| Regular Market Change Percent | 1.53257 |
| Regular Market Day High | 8.09 |
| Regular Market Day Low | 7.62 |
| Regular Market Day Range | 7.62 - 8.09 |
| Regular Market Open | 7.83 |
| Regular Market Previous Close | 7.83 |
| Regular Market Price | 7.95 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 271,582 |
| Return On Assets | 0.04221 |
| Return On Equity | 0.03675 |
| Revenue Growth | -0.298 |
| Revenue Per Share | 5.277 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 18,835,951 |
| Shares Percent Shares Out | 0.0612 |
| Shares Short | 1,151,850 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,459,450 |
| Short Name | OptimizeRx Corporation |
| Short Percent Of Float | 0.0641 |
| Short Ratio | 4.47 |
| Source Interval | 15 |
| State | MA |
| Symbol | OPRX |
| Target High Price | 18.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 12.4 |
| Target Median Price | 11.0 |
| Total Cash | 24,096,000 |
| Total Cash Per Share | 1.279 |
| Total Debt | 19,480,000 |
| Total Revenue | 98,654,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.25 |
| Trailing P E | 31.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.571 |
| Two Hundred Day Average Change | -0.6210003 |
| Two Hundred Day Average Change Percent | -0.072453655 |
| Type Disp | Equity |
| Volume | 271,582 |
| Website | https://www.optimizerx.com |
| Zip | 2,453 |